Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Exponent (EXPO) over the last 13 years, with Jan 2025 value amounting to $258.9 million.

  • Exponent's Cash & Equivalents fell 5.61% to $207.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $207.4 million, marking a year-over-year decrease of 5.61%. This contributed to the annual value of $258.9 million for FY2025, which is 38.34% up from last year.
  • As of FY2025, Exponent's Cash & Equivalents stood at $258.9 million, which was up 38.34% from $187.2 million recorded in FY2023.
  • Exponent's 5-year Cash & Equivalents high stood at $297.7 million for FY2021, and its period low was $161.5 million during FY2022.
  • For the 2-year period, Exponent's Cash & Equivalents averaged around $223.0 million, with its median value being $223.0 million (2023).
  • In the last 5 years, Exponent's Cash & Equivalents spiked by 50.71% in 2021 and then slumped by 45.76% in 2022.
  • Over the past 4 years, Exponent's Cash & Equivalents (Yearly) stood at $197.5 million in 2021, then surged by 50.71% to $297.7 million in 2021, then slumped by 45.76% to $161.5 million in 2022, then climbed by 15.91% to $187.2 million in 2023, then soared by 38.34% to $258.9 million in 2025.